150 related articles for article (PubMed ID: 30196444)
1. National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality.
Voskaridou E; Kattamis A; Fragodimitri C; Kourakli A; Chalkia P; Diamantidis M; Vlachaki E; Drosou M; Lafioniatis S; Maragkos K; Petropoulou F; Eftihiadis E; Economou M; Klironomos E; Koutsouka F; Nestora K; Tzoumari I; Papageorgiou O; Basileiadi A; Lafiatis I; Dimitriadou E; Kalpaka A; Kalkana C; Xanthopoulidis G; Adamopoulos I; Kaiafas P; Mpitzioni A; Goula A; Kontonis I; Alepi C; Anastasiadis A; Papadopoulou M; Maili P; Dionisopoulou D; Tsirka A; Makis A; Kostaridou S; Politou M; Papassotiriou I;
Ann Hematol; 2019 Jan; 98(1):55-66. PubMed ID: 30196444
[TBL] [Abstract][Full Text] [Related]
2. A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births.
Voskaridou E; Ladis V; Kattamis A; Hassapopoulou E; Economou M; Kourakli A; Maragkos K; Kontogianni K; Lafioniatis S; Vrettou E; Koutsouka F; Papadakis A; Mihos A; Eftihiadis E; Farmaki K; Papageorgiou O; Tapaki G; Maili P; Theohari M; Drosou M; Kartasis Z; Aggelaki M; Basileiadi A; Adamopoulos I; Lafiatis I; Galanopoulos A; Xanthopoulidis G; Dimitriadou E; Mprimi A; Stamatopoulou M; Haile ED; Tsironi M; Anastasiadis A; Kalmanti M; Papadopoulou M; Panori E; Dimoxenou P; Tsirka A; Georgakopoulos D; Drandrakis P; Dionisopoulou D; Ntalamaga A; Davros I; Karagiorga M;
Ann Hematol; 2012 Sep; 91(9):1451-8. PubMed ID: 22526366
[TBL] [Abstract][Full Text] [Related]
3. Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.
Vitrano A; Calvaruso G; Tesé L; Gioia F; Cassarà F; Campisi S; Butera F; Commendatore V; Rizzo M; Santoro V; Cigna V; Quota A; Bagnato S; Argento C; Fidone C; Schembari D; Gerardi C; Barbiera F; Bellisssima G; Giugno G; Polizzi G; Rosso R; Abbate G; Caruso V; Chiodi E; Gamberini MR; Giorgi B; Putti MC; Filosa A; De Ritis MR; Oliva E; Arcadi N; Fustaneo M; Mistretta L; Di Maggio R; Sacco M; Veronica DS; Giangreco A; Maggio A
Eur J Haematol; 2016 Oct; 97(4):361-70. PubMed ID: 26818147
[TBL] [Abstract][Full Text] [Related]
4. National registry of hemoglobinopathies in Spain (REPHem).
Cela E; Bellón JM; de la Cruz M; Beléndez C; Berrueco R; Ruiz A; Elorza I; Díaz de Heredia C; Cervera A; Vallés G; Salinas JA; Coll MT; Bermúdez M; Prudencio M; Argilés B; Vecilla C;
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27804209
[TBL] [Abstract][Full Text] [Related]
5. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
[TBL] [Abstract][Full Text] [Related]
6. Thirty-year experience in preventing haemoglobinopathies in Greece: achievements and potentials for optimisation.
Ladis V; Karagiorga-Lagana M; Tsatra I; Chouliaras G
Eur J Haematol; 2013 Apr; 90(4):313-22. PubMed ID: 23331260
[TBL] [Abstract][Full Text] [Related]
7. Management of iron overload in hemoglobinopathies.
Allali S; de Montalembert M; Brousse V; Chalumeau M; Karim Z
Transfus Clin Biol; 2017 Sep; 24(3):223-226. PubMed ID: 28673501
[TBL] [Abstract][Full Text] [Related]
8. Effect of deferasirox on iron overload in patients with transfusion-dependent haemoglobinopathies.
Fragomeno C; Roccabruna E; D'Ascola DG
Blood Cells Mol Dis; 2015 Dec; 55(4):382-6. PubMed ID: 26460263
[TBL] [Abstract][Full Text] [Related]
9. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
10. Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?
Coates TD; Carson S; Wood JC; Berdoukas V
Ann N Y Acad Sci; 2016 Mar; 1368(1):95-106. PubMed ID: 27186942
[TBL] [Abstract][Full Text] [Related]
11. Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).
Ho PJ; Tay L; Teo J; Marlton P; Grigg A; St Pierre T; Brown G; Badcock CA; Traficante R; Gervasio OL; Bowden DK
Eur J Haematol; 2017 Feb; 98(2):97-105. PubMed ID: 27537786
[TBL] [Abstract][Full Text] [Related]
12. Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.
Porter JB; Elalfy M; Taher A; Aydinok Y; Lee SH; Sutcharitchan P; El-Ali A; Han J; El-Beshlawy A
Eur J Haematol; 2017 Mar; 98(3):280-288. PubMed ID: 27859648
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants.
Theodoridou S; Prapas N; Balassopoulou A; Boutou E; Vyzantiadis TA; Adamidou D; Delaki EE; Yfanti E; Economou M; Teli Α; Karakasidou O; Skatharoudi E; Theodoridis T; Voskaridou E
Hemoglobin; 2018 Jul; 42(4):257-263. PubMed ID: 30501529
[TBL] [Abstract][Full Text] [Related]
14. Physiology and pathophysiology of iron in hemoglobin-associated diseases.
Coates TD
Free Radic Biol Med; 2014 Jul; 72():23-40. PubMed ID: 24726864
[TBL] [Abstract][Full Text] [Related]
15. Genetic Blood Disorders Survey in the Sultanate of Oman.
Al-Riyami A; Ebrahim GJ
J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
[TBL] [Abstract][Full Text] [Related]
16. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
[TBL] [Abstract][Full Text] [Related]
17. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload.
Puliyel M; Sposto R; Berdoukas VA; Hofstra TC; Nord A; Carson S; Wood J; Coates TD
Am J Hematol; 2014 Apr; 89(4):391-4. PubMed ID: 24347294
[TBL] [Abstract][Full Text] [Related]
18. Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia.
Bardón-Cancho EJ; Marco-Sánchez JM; Benéitez-Pastor D; Payán-Pernía S; Llobet AR; Berrueco R; García-Morin M; Beléndez C; Senent L; Acosta MJO; Pleguezuelos IP; Velasco P; Collado A; Moreno-Carbonell M; Argilés B; de Soto IP; Del Mar Bermúdez M; Salido Fiérrez EJ; Blanco-Álvarez A; Navarro PG; Cela E
Ann Hematol; 2024 May; 103(5):1525-1539. PubMed ID: 38519604
[TBL] [Abstract][Full Text] [Related]
19. Regulation of iron absorption in hemoglobinopathies.
Rechavi G; Rivella S
Curr Mol Med; 2008 Nov; 8(7):646-62. PubMed ID: 18991651
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
